Search company, investor...

Vemos

vemos.com.br

Stage

Seed | Alive

Total Raised

$210K

Last Raised

$210K | 7 yrs ago

About Vemos

Vemos is a platform for managing mobile service bills and accounts. It analyzes monthly invoices for billing errors and provides retroactive audits.

Headquarters Location

Sao Paulo,

Brazil

+55 1142004966

Missing: Vemos's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Vemos's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Vemos

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Vemos is included in 1 Expert Collection, including Fintech.

F

Fintech

4,841 items

Latest Vemos News

Martín Vizcarra: la vacuna contra el COVID-19 no la vamos a tener antes de fin de año

Jul 22, 2020

“Vemos los avances de la vacuna. Vienen de tres potencias en ciencia. Hablamos de Reino Unidos, China y Estados Unidos que nos hacen ver que estamos avanzando en lograr la vacuna tan ansiada para que la ciudadanía tenga inmunidad al COVID-19. Si bien los avances son alentadores y satisfactorios hay que ser absolutamente sinceros, no vienen en el corto plazo”, refirió en conferencia de prensa virtual. Martín Vizcarra: "Vacuna es solución para mediano plazo" “Alguno cree que porque se entra a la fase 3 de la vacuna, en un mes o tres meses tendremos la vacuna. Sí, son alentadores los resultados y felicitamos del avance de la ciencia, pero la vacuna no la vamos a tener antes de fin de año. Es imposible que la tengamos, con todos los protocolos científicos que debe cumplir una vacuna, antes de fin de año”, comentó. Esta semana, la vacuna contra el COVID-19, que está desarrollando la Universidad de Oxford, en Reino Unido, generó grandes expectativas, tras mostrar que es segura y capaz de provocar una respuesta inmune en la fase de pruebas. Los ensayos, en los que participaron 1.077 personas, mostraron que la vacuna genera anticuerpos y las llamadas células T que pueden combatir el coronavirus.

Vemos Frequently Asked Questions (FAQ)

  • Where is Vemos's headquarters?

    Vemos's headquarters is located at Sao Paulo.

  • What is Vemos's latest funding round?

    Vemos's latest funding round is Seed.

  • How much did Vemos raise?

    Vemos raised a total of $210K.

  • Who are the investors of Vemos?

    Investors of Vemos include WOW Aceleradora.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.